Education
About Us
Working with TipRanks
Follow Us
Waradana Malitha Hashan De Silva Insider Profile
4 Followers
Waradana Malitha Hashan De Silva, Director at Pharmaxis Ltd, holds 64.22M shares in Pharmaxis Ltd (Ticker: AU:SNT), holds 12.06M shares in Curvebeam AI Ltd. (Ticker: AU:CVB). Most recently, Waradana Malitha Hashan De Silva Bought ― shares of Pharmaxis Ltd on Mar 14, 2025 for an estimated value of 585.21K.
Waradana Malitha Hashan De Silva Pharmaxis Ltd (SNT)Director
Pharmaxis Ltd (SNT)
Director
Ranked #87,306 out of 102,674 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-25.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Waradana Malitha Hashan De Silva holds in companies
Most Profitable Insider Trade
The most profitable trade made by Waradana Malitha Hashan De Silva
Waradana Malitha Hashan De Silva's Trading History
Pharmaxis Ltd
Mar 14, 2025
Director
Informative Buy
585.21K
AU$3.85M
Curvebeam AI Ltd.
Dec 16, 2024
Director
Uninformative Buy
5.66K
AU$1.02M
List of latest transactions for each holding click on a transaction to see Waradana Malitha Hashan De Silva's performance on stock
You May Also Like
Waradana Malitha Hashan De Silva insider profile FAQ
What is the percentage of profitable transactions made by Waradana Malitha Hashan De Silva?
The percentage of profitable transactions made by Waradana Malitha Hashan De Silva is 17%.
What is the average return per transaction made by Waradana Malitha Hashan De Silva?
The average return per transaction made by Waradana Malitha Hashan De Silva is -25.00%.
What stocks does Waradana Malitha Hashan De Silva hold?
Waradana Malitha Hashan De Silva holds: AU:SNT, AU:CVB stocks.
What was Waradana Malitha Hashan De Silva’s latest transaction?
Waradana Malitha Hashan De Silva latest transaction was an Informative Buy of AU$585.21K.
What was Waradana Malitha Hashan De Silva's most profitable transaction?
Waradana Malitha Hashan De Silva’s most profitable transaction was an Informative Buy of AU:SNT stock on September 24, 2024. The return on the trade was 69.60%.
What is Waradana Malitha Hashan De Silva's role in Pharmaxis Ltd?
Waradana Malitha Hashan De Silva's role in Pharmaxis Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.